Nautilus Biotechnology, Inc. Cash and Restricted Cash
Nautilus Biotechnology, Inc. (NAUT) had Cash and Restricted Cash of $14.17 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-28
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.17M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.63M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.39M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.88M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $14.17M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $15.63M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $13.39M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $24.88M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $35.46M 10-Q · filed 2026-07-28 | |
| 2025-03-31 | $34.24M 10-Q · filed 2026-04-28 | |
| 2024-12-31 | $28.65M 10-Q · filed 2026-07-28 | |
| 2024-09-30 | $5.41M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $25.89M 10-Q · filed 2025-07-31 | |
| 2024-03-31 | $26.73M 10-Q · filed 2025-04-29 | |
| 2023-12-31 | $20.40M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $75.11M 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $73.75M 10-Q · filed 2024-07-30 | |
| 2023-03-31 | $89.46M 10-Q · filed 2024-04-30 | |
| 2022-12-31 | $115.48M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $189.77M 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $211.20M 10-Q · filed 2023-08-02 | |
| 2022-03-31 | $189.46M 10-Q · filed 2023-05-02 | |
| 2021-12-31 | $186.46M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $190.85M 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $289.00M 10-Q · filed 2022-08-02 | |
| 2021-03-31 | $52.41M 10-Q · filed 2022-05-03 | $682.01K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $37.22M 10-K · filed 2023-02-23 | $1.00M 10-K · filed 2021-03-30 |
| 2020-09-30 | $13.24M 10-Q · filed 2021-11-02 | $1.06M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $32.87M 10-Q · filed 2021-08-10 | $0.00 10-Q · filed 2020-09-18 |
| 2020-03-26 | $0.00 10-K · filed 2021-03-30 | |
| 2019-12-31 | $595.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |